?>
 

 
 
 
    Steroid profiles
    Anadrol
    Anavar
    Andriol
    Arimidex
    Clenbuterol
    Clomid
    Cytomel
    Deca-Durabolin
    Dianabol
    Durabolin
    Ephedrine
    EPO / Erythropoietin
    Equipoise
   Femara
    Halotestin
    HCG
    Human Growth Hormone
    Insulin
    Lasix
    Masteron
    Nolvadex / Tamoxifen
    Omnadren 250
    Primobolan Depot
    Primobolan tabs
    Proviron
    Sustanon
    Testosterone cypionate
    Testosterone enanthate
    Testosterone propionate
    Testosterone suspension
    Trenbolone Acetate
    Winstrol

   Steroid articles
 Safe steroids
 The new form of drug abuse
 Save or savage?
 Fast Weight Loss Diet
 Hair Loss Product
 Hair Loss
 Short cycles / good gains - less sides
 Blood testing / a necessity in AAS usage
 Solid Cycles for Different Goals
 Nolvadex vs. Clomid for PCT
 Insulin

   Menu
    STEROID PROFILES
    Steroid discussions
    Chemistry in anabolics
    General anabolic discussion
    Discussion about training
    Discussion about other sports
    Disclaimer
    Search

   Supplements profiles
Syntrax Syntra EC
Universal Amino 1000
VPX Muscle Nitrous
Universal Animal Pak
Muscletech LEUKIC Hardcore
Premium NO-CRE-X3
Gaspari MyoFusion
Cytosport Joint Matrix
Inner Armour Creatine
Universal Tribulus Pro
San Shredded
Dymatize Super Multi
Universal Animal Test
NOW Phosphatidyl Serine
NOW ADAM™ Superior Men's Multiple Vitamin
NOW Tru Hoodia Complex
Universal Glutamine Powder
VPX Fiberteq
Optimum Superior Amino 2222 Capsules
Syntrax GLUFM
Nutrex Lipo 6 Pro-Natural
Optimum Complete Diet Boost
Gaspari PlasmaJet
BSN True Mass
Dymatize GABA


   What is going on?

There are 57 guests on-line




  Femara - description and photos

Active Life: 2-4 days
Drug Class: Aromatase inhibitor (Oral)
Average Dose: 0.5 - 2.5 mg/day
Acne: Yes
Water Retention: No
High Blood Pressure: May reduce bp when using aronatizable steroids
Liver Toxic: Yes, dose dependant
Decrease HPTA function: No

Femara (generic name is letrozole) is a new drug developed for the treatment of advanced breast cancer in women. Femara is the second in a new class of third-generation selective oral aromatase inhibitors.. It acts by blocking the enzyme aromatase, subsequently blocking the production of estrogen. Since many forms of breast cancer cells are stimulated by estrogen, it is hoped that by reducing amounts of estrogen in the body the progression of such a disease can be halted. This is the basic premise behind Nolvadex, except this drug blocks the action and not production of estrogen. The effects of Femara can be quite dramatic to say the least. A daily dose of one tablet (2.5 mg) can produce estrogen suppression greater than 80 % in treated patients. With the powerful effect this drug has on hormone levels, it is only to be used (clinically) by post-menopausal women whose disease has progressed following treatment with Nolvadex. Side effects like hot flushes and hair thinning can be present, and would no doubt be much more severe in pre-menopausal patients.

For the steroid using male athlete, Femara shows great potential. Up to this point, drugs like Nolvadex and Proviron have been our weapons against excess estrogen. These drugs, especially in combination, do prove quite effective. But Femara appears able to do the job much more efficiently, and with less hassle. Its use is only now catching on, but early reports have been excellent. A single tablet daily, the same dose use clinically, seems to be all one needs for an exceptional effect (some even report excellent results with only 1/4 tablet daily). When used with strong, readily aromatizing androgens such as Dianabol or testosterone, gynecomastia and water retention can be effectively blocked. In combination with Propecia (finasteride), we have a great advance. With the one drug halting estrogen conversion and the other blocking 5-alpha reduction (testosterone, methyltestosterone and Halotestin only), related side effects can be effectively minimized. Here the strong androgen testosterone could theoretically provide incredible muscular growth, while at the same time being as tolerable as nandrolone. Additionally the quality of the muscle should be greater, the athlete appearing harder and much more defined without holding excess water.

There are some concerns with using an aromatase inhibitor such as this during prolonged steroid treatment however. While it will effectively reduce estrogenic side effects, it will also block the beneficial properties of estrogen from becoming apparent (namely its effect on cholesterol values). Studies have clearly shown that when an aromatase inhibitor is used in conjunction with a steroid such as testosterone, suppression of HDL (good) cholesterol becomes much more pronounced. Apparently estrogen plays a role in minimizing the negative impact of steroid use. Since the estrogen receptor antagonist Nolvadex does not display an anti-estrogenic effect on cholesterol values, it is the preferred from of estrogen maintenance for those concerned with cardiovascular health.

Femara has another principle drawback, namely the great price of this drug. Tablets can be quite costly with regular use, but it can ward off the side effects of strong androgens much better than Nolvadex and/or Proviron, making heavy cycles much more comfortable. As the number of countries manufacturing this drug increases, we may be able to look forward to a reduction in price. Privately compounded versions of "liquid Femara have also been formulated "for research purposes" and are currently circulating the black market. Generic tabs are also available and these two forms represent a very cost-effective alternative for buying the brand name drug.

Source - steroidology

 


(c) 2001-2009 www.silownia.net